Waypoint Capital Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-90,989
| Closed | -$2.3M | – | 136 |
|
|
2023
Q2 | $2.3M | Hold |
90,989
| – | – | 0.72% | 39 |
|
|
2023
Q1 | $2.93M | Buy |
90,989
+37,000
| +69% | +$1.19M | 0.95% | 32 |
|
|
2022
Q4 | $997K | Buy |
+53,989
| New | +$997K | 0.35% | 63 |
|
|
2022
Q2 | – | Sell |
-53,989
| Closed | -$1.02M | – | 142 |
|
|
2022
Q1 | $1.02M | Buy |
+53,989
| New | +$1.02M | 0.6% | 44 |
|